Try our Advanced Search for more refined results

Expert Analysis

Authenticating Art With Bioengineered DNA: The IP Issues

Law360, New York ( November 2, 2015, 11:43 AM EST) -- Recently making the rounds in the media circuit are reports on a fascinating new authentication system that would allow living artists to effectively "sign" their artworks with very small amounts of synthetic DNA. [1] This new authentication system is encompassed more broadly within "i2M," a new standards-based technology that is uniquely developed to provide an industrywide solution to the long-standing problem of faked, forged and stolen art in the art world. [2] This article provides an overview of the i2M Standards and addresses the legal implications of the i2M Standards technology from an intellectual property perspective. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies